Fig. 1
From: Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
CONSORT diagram for paclitaxel, ganitumab, metformin arm in I-SPY2.
Fig. 1 | npj Breast Cancer
From: Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
CONSORT diagram for paclitaxel, ganitumab, metformin arm in I-SPY2.
